Skip to content
Study details
Enrolling now

The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial

Main Line Health
NCT IDNCT06439524ClinicalTrials.gov data as of Apr 2026
Phase

Phase 3

Target enrollment

110

Study length

about 2 years

Ages

18+

Sex

Female only

Locations

1 site in PA

What this study is about

This trial is testing whether taking Relugolix combination therapy (Rel-CT) after excisional surgery for endometriosis improves quality of life compared to not taking it. Participants will complete questionnaires about their health and well-being at different time points following the surgery.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take 40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
OralOral

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Progestational Hormone Receptor Agonists), estradiol, relugolix

Drug routes

oral (Oral Tablet)

Body systems

Reproductive Health